Diagnostic Pathology

Table 2 Expression of MTA3 mRNA and protein in the 118 NSCLC cases

From: Analysis of MAT3 gene expression in NSCLC

Parameter	MTA3 mRNA		MTA3 protein
	Expression level	P value	n		P value
	Expression level	P value	Negative	Positive	P value
Gender
Male	0.2547 ± 0.10485	0.581	24	35	1.000
Female	0.2442 ± 0.10298		24	35	1.000
Age (years)
≥60	0.2646 ± 0.09439	0.073	21	45	0.038*
<60	0.2302 ± 0.11224		27	25	0.038*
Histology
Adeno	0.2444 ± 0.10711	0.534	29	40	0.849
SCC	0.2565 ± 0.09913		19	30	0.849
Differentiation
Well	0.2234 ± 0.11671	0.038*	28	18	0.001*
Moderate-poor	0.2661 ± 0.09131		20	52	0.001*
Tumor stage
T1	0.2233 ± 0.10521		22	17	0.018*
T2	0.2485 ± 0.10680	0.030*	21	34
T3–4	0.2942 ± 0.07934		5	19
TNM stage
I	0.2350 ± 0.10463	0.079	28	24	0.018*
II	0.2435 ± 0.10970		15	27
III	0.2913 ± 0.08077		5	19
Nodal status
Positive	0.2810 ± 0.08593	0.003*	10	39	0.000*
Negative	0.2270 ± 0.10969		38	31	0.000*

*Indicated statistical significance (P < 0.05).

Back to article page

ISSN: 1746-1596

Contact us

Submission enquiries: journalsubmissions@springernature.com